The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 28, 2023

Filed:

Mar. 31, 2021
Applicant:

Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, CN;

Inventors:

Lei Chen, Taizhou, CN;

Dongliang Guan, Taizhou, CN;

Hua Bai, Taizhou, CN;

Jun Gou, Taizhou, CN;

Weifeng Zhao, Taizhou, CN;

Zhongli Wang, Taizhou, CN;

Long Ling, Taizhou, CN;

Yutao Ma, Taizhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 403/14 (2006.01); C07D 403/12 (2006.01); C07D 471/10 (2006.01); C07D 487/10 (2006.01); A61P 35/00 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/14 (2013.01); A61K 31/506 (2013.01); A61P 35/00 (2018.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 471/10 (2013.01); C07D 487/10 (2013.01); Y02P 20/55 (2015.11);
Abstract

The present invention relates to a pyrimidine derivative, a method for preparing same and use thereof in medicine. In particular, the present invention relates to a pyrimidine derivative represented by general formula (I), a method for preparing same and a pharmaceutically acceptable salt thereof as well as use thereof as a therapeutic agent, in particular as a FGFR4 kinase inhibitor, definitions of each substituent in the general formula (I) being the same as those defined in the description.


Find Patent Forward Citations

Loading…